SERUM VALUES OF PEPSINOGENS AND ANTIBODIES TO HELICOBACTER-PYLORI IN RELATION TO A HISTORY OF PEPTIC-ULCER DISEASE AND NSAID USE

被引:2
作者
JANSSEN, M
DIJKMANS, BAC
VANDENBROUCKE, JP
BIEMOND, I
VANDUYN, W
ZWINDERMAN, AH
LAMERS, CBHW
机构
[1] UNIV LEIDEN HOSP,DEPT RHEUMATOL,2300 RC LEIDEN,NETHERLANDS
[2] UNIV LEIDEN HOSP,DEPT CLIN EPIDEMIOL,2300 RC LEIDEN,NETHERLANDS
[3] UNIV LEIDEN HOSP,DEPT GASTROENTEROL,2300 RC LEIDEN,NETHERLANDS
[4] UNIV LEIDEN HOSP,DEPT MED STAT,2300 RC LEIDEN,NETHERLANDS
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SERUM PEPSINOGENS; HELICOBACTER PYLORI; GASTRITIS; RHEUMATOID ARTHRITIS; PEPTIC ULCER DISEASE;
D O I
10.3109/03009749509100874
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study was undertaken to investigate whether patients with a history of peptic ulcer disease (PUD) have serological features indicative of the presence of more severe gastritis, compared to patients without a history of PUD. In addition we investigated whether current chronic use of non steroidal anti-inflammatory drugs (NSAIDs) was associated with serological features indicative of a chemical (type C) gastritis. In total 850 consecutive outclinic patients were interviewed by a standard questionnaire with emphasis on demographic data, diagnosis, chronic use of NSAID, and history of PUD. Serum pepsinogen A (PgA) and pepsinogen C (PgC), the PgA:PgC ratio, and IgA and IgG antibodies to H. pylori were measured in all patients. After controlling for age, sex, H, pylori seropositivity, and presence of RA, a correlation was found between a decreased pepsinogen A:C ratio and the use of NSAID. Patients with a history of PUD have serological features indicative of a persistently more severe gastritis. Secondly we found serological evidence for the existence of a chemical (type C) gastritis in NSAID users.
引用
收藏
页码:204 / 208
页数:5
相关论文
共 29 条
[1]   NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND LIFE THREATENING COMPLICATIONS OF PEPTIC-ULCERATION [J].
ARMSTRONG, CP ;
BLOWER, AL .
GUT, 1987, 28 (05) :527-532
[2]  
BIEMOND I, 1989, J CLIN CHEM CLIN BIO, V27, P19
[3]   HELICOBACTER-PYLORI AND THE PATHOGENESIS OF GASTRODUODENAL INFLAMMATION [J].
BLASER, MJ .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) :626-633
[4]   THE RATIO OF PEPSINOGEN-A TO PEPSINOGEN-C - A SENSITIVE TEST FOR ATROPHIC GASTRITIS [J].
BORCH, K ;
AXELSSON, CK ;
HALGREEN, H ;
NIELSEN, MD ;
LEDIN, T ;
SZESCI, PB .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1989, 24 (07) :870-876
[5]   NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND PEPTIC-ULCER PERFORATION [J].
COLLIER, DS ;
PAIN, JA .
GUT, 1985, 26 (04) :359-363
[6]   THE CLINICAL-SIGNIFICANCE OF CAMPYLOBACTER-PYLORI [J].
DOOLEY, CP ;
COHEN, H .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (01) :70-79
[7]   NONSTEROIDAL ANTIINFLAMMATORY DRUG-ASSOCIATED GASTROPATHY - INCIDENCE AND RISK FACTOR MODELS [J].
FRIES, JF ;
WILLIAMS, CA ;
BLOCH, DA ;
MICHEL, BA .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 (03) :213-222
[8]  
HENGELS KJ, 1985, GASTROENTEROLOGY, V94, P1417
[9]   RADIOIMMUNOASSAY OF SERUM GROUP-I AND GROUP-II PEPSINOGENS IN NORMAL CONTROLS AND PATIENTS WITH VARIOUS DISORDERS [J].
ICHINOSE, M ;
MIKI, K ;
FURIHATA, C ;
KAGEYAMA, T ;
HAYASHI, R ;
NIWA, H ;
OKA, H ;
MATSUSHIMA, T ;
TAKAHASHI, K .
CLINICA CHIMICA ACTA, 1982, 126 (02) :183-191
[10]  
JANSSEN M, 1992, BRIT J RHEUMATOL, V31, P747